Template:CMV neurologic disease treatment: Difference between revisions

No edit summary
(Strip translate tags to enable SMW subobject creation)
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
<noinclude><languages/></noinclude>
*{{AntibioticDose|disease=CMV neurologic disease|drug=Ganciclovir|dose=5mg/kg IV q12hrs x 21 days then 5mg/kg IV q24hrs|context=Combined with Foscarnet|population=Adult}} +
<translate>
**{{AntibioticDose|disease=CMV neurologic disease|drug=Foscarnet|dose=90mg/kg IV q12hrs x 21 days then 90-120mg/kg IV q24hrs|context=Combined with Ganciclovir|population=Adult}}
*[[Special:MyLanguage/Ganciclovir|Ganciclovir]] 5mg/kg IV q12hrs daily x 21 days FOLLOWED BY 5mg/kg IV q24hrs +
**[[Special:MyLanguage/Foscarnet|Foscarnet]] 90mg/kg IV q12hrs x 21 days THEN 90-120mg/kg IV q24hrs
</translate>

Latest revision as of 02:54, 20 March 2026

  • Ganciclovir 5mg/kg IV q12hrs x 21 days then 5mg/kg IV q24hrs +
    • Foscarnet 90mg/kg IV q12hrs x 21 days then 90-120mg/kg IV q24hrs
Retrieved from "https://www.wikem.org/w/index.php?title=Template:CMV_neurologic_disease_treatment&oldid=386618"